Principal Financial Group’s Madrigal Pharmaceuticals MDGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.79M | Buy |
|
|||||
|
2025
Q1 | $475K | Sell |
|
|||||
|
2024
Q4 | $472K | Sell |
|
|||||
|
2024
Q3 | $345K | Sell |
|
|||||
|
2024
Q2 | $856K | Sell |
|
|||||
|
2024
Q1 | $1.07M | Buy |
|
|||||
|
2023
Q4 | $897K | Buy |
|
|||||
|
2023
Q3 | $545K | Sell |
|
|||||
|
2023
Q2 | $880K | Sell |
|
|||||
|
2023
Q1 | $952K | Sell |
|
|||||
|
2022
Q4 | $1.22M | Buy |
|
|||||
|
2022
Q3 | $249K | Sell |
|
|||||
|
2022
Q2 | $279K | Buy |
|
|||||
|
2022
Q1 | $210K | Buy |
|
|||||
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $254K | Sell |
|
|||||
|
2021
Q2 | $360K | Sell |
|
|||||
|
2021
Q1 | $625K | Sell |
|
|||||
|
2020
Q4 | $601K | Buy |
|
|||||
|
2020
Q3 | $383K | Sell |
|
|||||
|
2020
Q2 | $383K | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $211K | Buy |
|
|||||
|
2019
Q3 | – | Sell |
|
|||||
|
2019
Q2 | $236K | Buy |
|
|||||
|
2019
Q1 | $278K | Buy |
|
|||||
|
2018
Q4 | $230K | Sell |
|
|||||
|
2018
Q3 | $1.99M | Buy |
|
|||||
|
2018
Q2 | $2.45M | Buy |
|
|||||
|
2016
Q2 | – | Sell |
|
|||||
|
2016
Q1 | $4K | Hold |
|
|||||
|
2015
Q4 | $5K | Hold |
|
|||||
|
2015
Q3 | $27K | Sell |
|
|||||
|
2015
Q2 | $55K | Buy |
|
|||||
|
2015
Q1 | $36K | Sell |
|
|||||
|
2014
Q4 | $50K | Buy |
|
|||||
|
2013
Q3 | – | Sell |
|
|||||
|
2013
Q2 | $109K | Buy |
|